I. Introduction
Cellular reprogramming opens the door for personalized regenerative medicine especially in fight with chronic and degenerative disease. We have established a technology converting the cells from urine into neural progenitor cells (NPC), so called trans-differentiation. This technology can allow us easily obtain source cells in a noninvasive approach. However, further studies we found that, during the trans-differentiation process, along with positive NPCs, the negative colonies have different sub type of morphology and polarity. As we understand, the cellular polarity strongly linked with gene expression, cell cycle and other cellular regulation may explain the mechanism regarding the different route of reprogramming. For example cell polarity changes between MET and EMT which linked with induced pluripotent stem cell (iPSCs) colony formation or tumor genesis. Hence, the regulation of cell fate changes has a strong link with morphology as a read out.